Darya Chudova - 08 Dec 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Issuer symbol
GH
Transactions as of
08 Dec 2025
Net transactions value
-$2,417,980
Form type
4
Filing time
10 Dec 2025, 21:31:37 UTC
Previous filing
02 Oct 2025
Next filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chudova Darya Chief Technology Officer 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Darya Chudova 10 Dec 2025 0001977179

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Other $0 -68,144 -76% $0.000000 21,734 08 Dec 2025 Direct F1
transaction GH Common Stock Other $0 +68,144 $0.000000 68,144 08 Dec 2025 Chudova Family Trust
transaction GH Common Stock Sale $982,753 -9,271 -43% $106.00 12,463 08 Dec 2025 Direct F2
transaction GH Common Stock Sale $1,435,227 -13,664 -20% $105.04 54,480 08 Dec 2025 Chudova Family Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects changes in form of ownership from direct to indirect due to transfer of shares to The Chudova Family Trust.
F2 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.11. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.24. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

Table I includes 488 shares acquired under the Guardant Health's Employee Stock Purchase Plan on 5/14/2023.